Low PSA score after radiation can predict prostate cancer returnA consortium of prostate cancer experts have discovered, through a clinical investigation, that prostate cancer patients who have a lower prostate specific antigen (PSA) score after radiation therapytext editor...
Effect of the Cluster randomized trial of PSA testing for Prostate cancer (CAP) trial intervention on the cumulative incidence of all-cause mortality eFigure 7. Cumulative incidence of prostate cancer in intervention-group non-attenders for PSA screening vs controls (A) and in the post-screening...
Triage of low-risk prostate cancer patients with PSA levels 10 ng/ml or less: comparison of apparent diffusion coefficient value and transrectal ultrasound... Triage of low-risk prostate cancer patients with PSA levels 10 ng/ml or less: comparison of apparent diffusion coefficient value and ...
Death Register, so they could calculate numbers of deaths from prostate cancer in the cohort and ...
prostate-specific antigen (PSA) biochemical recurrence, indicating tumor progression (disease-free survival mean = 25.8 months, median = 31.5 months), see Table1. Standard clinical data such as Gleason score, cancer stage, pre-operative PSA value, and age did not allow accurate ...
1938 PROSTATE SPECIFIC ANTIGEN (PSA)-BASED SCREENING FOR PROSTATE CANCER IS UNLIKELY A RISK FACTOR TO DETECT CLINICALLY INSIGNIFICANT CANCER IN JAPANESE ELDERLY MEN May 7, 2013 03:30 PMProstate Cancer: Detection & Screening (III)NoneAlthough the screening for prostate cancer (PCa) using PSA has ...
PSA indicates prostate-specific antigen. Figure 2. Kaplan-Meier Survival Curves With Testosterone Therapy Evaluated as a Time-Varying Covariate View LargeDownload Table 1. Characteristics of Patients at Study Entry Who Did and Did Not Receive Testosterone Therapy View LargeDownload Table 2. P Values ...
Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core In this paper several advances were implemented for glycoprofiling of prostate specific antigen (PSA), what can be applied for better prostate cancer (PC...
DETECTION OF PROSTATE CANCER USING PSA GLYCOSYLATION PATTERNS The present invention features novel methods for determining if a subject has prostate cancer. The present invention is based on the development of lectin immunosorbant assays which analyze 伪2,6-linked sialylation of total serum PSA by ....
nPSA is a strong independent predictor of freedom from PSA failure and PFS in patients with low and intermediate-risk localized prostate cancer treated with RT alone. Longer follow-up and larger patient numbers are required to confirm these observations. 展开 ...